Standardize the application of new biomedical technologies to promote the construction of a healthy China.

The State Council executive meeting held on the 12th approved the "Regulations on the Management of Biomedical New Technology Clinical Research and Clinical Transformation Application". The meeting pointed out the need to promote the innovation and development of biomedical technology in China, accelerate technological research and development and the application of results, promote the upgrading of the biomedical industry, and focus on shaping new advantages for development. Industry insiders believe that regulating the clinical research and application of new biomedical technologies aims to promote medical progress, ensure the quality and safety of medical care, and safeguard human dignity and life and health. The formulation of the regulations not only helps to break through the barriers between research and transformation mechanisms, accelerate the benefits of a batch of cutting-edge biomedical technologies to the public, but also clarifies the responsibilities of research units, enterprises, medical institutions, etc., strengthens risk warning and emergency control, and sets clear "red lines" and "bottom lines" for innovative activities, which is an important step towards modernizing the governance system and governance capacity in this field.